35. Jahrestagung Der Deutschen Arbeitsgemeinschaft Zum Studium Der Leber 2019
DOI: 10.1055/s-0038-1677277
|View full text |Cite
|
Sign up to set email alerts
|

Erste Erfahrung mit dem pangenotypischen Therapieregime Glecaprevir/Pibrentasvir (Maviret) zur Behandlung einer chronischen Hepatitis C Infektion

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles